Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 46: 1751-1754, 2000;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (49)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Alatalo, S. L.
Right arrow Articles by Väänänen, H. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alatalo, S. L.
Right arrow Articles by Väänänen, H. K.
Related Collections
Right arrow Proteomics and Protein Markers
(Clinical Chemistry. 2000;46:1751-1754.)
© 2000 American Association for Clinical Chemistry, Inc.

Articles

Rapid Screening Method for Osteoclast Differentiation in Vitro That Measures Tartrate-resistant Acid Phosphatase 5b Activity Secreted into the Culture Medium

Sari L. Alatalo1,a, Jussi M. Halleen1, Teuvo A. Hentunen1,2, Jukka Mönkkönen3 and H. Kalervo Väänänen1

1 Institute of Biomedicine, Department of Anatomy, University of Turku, Kiinamyllynkatu 10, FIN-20520 Turku, Finland.

2 Cell Test Turku Ltd, FIN-20520 Turku, Finland.

3 Department of Pharmaceutics, University of Kuopio, FIN-70210 Kuopio, Finland.
a Author for correspondence. Fax 358-2-333 7352; e-mail saleal{at}utu.fi

Background: Osteoclasts secrete tartrate-resistant acid phosphatase (TRAP; EC 3.1.3.2) 5b into the circulation. We studied the release of TRAP 5b from osteoclasts using a mouse in vitro osteoclast differentiation assay.

Methods: We developed and characterized a polyclonal antiserum in rabbits, using purified human osteoclastic TRAP 5b as antigen. The antiserum was specific for TRAP in Western analysis of mouse osteoclast culture medium and was used to develop an immunoassay. We cultured mouse bone marrow-derived osteoclast precursor cells for 3–7 days with or without clodronate in the presence of vitamin D and analyzed the number of osteoclasts formed and the amount of TRAP 5b activity released into the culture medium.

Results: TRAP 5b activity was not secreted from osteoclast precursor cells. Addition of clodronate-containing liposomes decreased in a dose-dependent manner the number of osteoclasts and TRAP 5b activity released in 6-day cultures. The amount of TRAP 5b activity in the medium detected by the immunoassay correlated significantly with the number of osteoclasts formed (r = 0.94; P <0.0001; n = 120).

Conclusions: The TRAP 5b immunoassay can be used to replace the laborious and time-consuming microscopic counting of osteoclasts in the osteoclast differentiation assay and to test the effects of potential therapeutic agents on osteoclast differentiation, enabling fast screening of large amounts of potential therapeutic agents.




The following articles in journals at HighWire Press have cited this article:


Home page
 Mol. Cell. Biol.Home page
V. Munugalavadla, S. Vemula, E. C. Sims, S. Krishnan, S. Chen, J. Yan, H. Li, P. J. Niziolek, C. Takemoto, A. G. Robling, et al.
The p85{alpha} Subunit of Class IA Phosphatidylinositol 3-Kinase Regulates the Expression of Multiple Genes Involved in Osteoclast Maturation and Migration
Mol. Cell. Biol., December 1, 2008; 28(23): 7182 - 7198.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
F. Lamoureux, P. Richard, Y. Wittrant, S. Battaglia, P. Pilet, V. Trichet, F. Blanchard, F. Gouin, B. Pitard, D. Heymann, et al.
Therapeutic Relevance of Osteoprotegerin Gene Therapy in Osteosarcoma: Blockade of the Vicious Cycle between Tumor Cell Proliferation and Bone Resorption
Cancer Res., August 1, 2007; 67(15): 7308 - 7318.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
Q. Wang, M. Alen, P. H. F. Nicholson, J. M. Halleen, S. L. Alatalo, C. Ohlsson, H. Suominen, and S. Cheng
Differential Effects of Sex Hormones on Peri- and Endocortical Bone Surfaces in Pubertal Girls
J. Clin. Endocrinol. Metab., January 1, 2006; 91(1): 277 - 282.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
T.-Y. Chao, J.-C. Yu, C.-H. Ku, M. M. Chen, S.-H. Lee, A. J. Janckila, and L. T. Yam
Tartrate-Resistant Acid Phosphatase 5b is a Useful Serum Marker for Extensive Bone Metastasis in Breast Cancer Patients
Clin. Cancer Res., January 15, 2005; 11(2): 544 - 550.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
S. L. Alatalo, K. K. Ivaska, S. G. Waguespack, M. J. Econs, H. K. Vaananen, and J. M. Halleen
Osteoclast-Derived Serum Tartrate-Resistant Acid Phosphatase 5b in Albers-Schonberg Disease (Type II Autosomal Dominant Osteopetrosis)
Clin. Chem., May 1, 2004; 50(5): 883 - 890.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. K. Ivaska, T. A. Hentunen, J. Vaaraniemi, H. Ylipahkala, K. Pettersson, and H. K. Vaananen
Release of Intact and Fragmented Osteocalcin Molecules from Bone Matrix during Bone Resorption in Vitro
J. Biol. Chem., April 30, 2004; 279(18): 18361 - 18369.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pathol.Home page
H Bull, P G Murray, D Thomas, A M Fraser, and P N Nelson
Acid phosphatases
Mol. Pathol., April 1, 2002; 55(2): 65 - 72.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the American Association for Clinical Chemistry.